iO Life Science

What iO Life Science does

iO Life Science is a privately held, Redwood City-based virtual MedTech incubator founded in 2015 that operates with a lean team of 1-10 employees. The firm partners with MedTech founders and pharma/biotech executives to deliver combined funding, engineering, and execution services across the medical device development lifecycle, from concept through regulatory submission. Its service stack is built around a proprietary "Compliant Human-Centered Innovation" methodology and direct working knowledge of ISO 13485, ISO 14971, IEC 62366-1, and IEC 62304 — the standards governing medical device quality systems, risk management, usability engineering, and software lifecycle processes.

The firm has supported more than 20 MedTech startups to date and has produced three successful exits from its portfolio. Its client base spans both early-stage device startups and tier-1 pharmaceutical companies, with Novartis, AbbVie, and AstraZeneca named as enterprise reference clients. Active case studies span neurology, ophthalmology, orthopedics, pulmonology, and remote patient monitoring, indicating breadth across therapeutic verticals. The firm's deliverables include integrated Design History Files and supplier qualifications, which are core regulatory artifacts required for FDA and CE-mark submissions.

iO Life Science generates revenue through a hybrid model: milestone-based Statements of Work (SOWs) for engineering and regulatory services, equity participation in client startups, and direct investment through iO Life Ventures — a dedicated capital arm. The company also positions itself as a "fractional COO" for MedTech founders, bundling capital, regulatory, and engineering capabilities into a single outsourced operating function. Pricing is not publicly disclosed, and the virtual operating model allows the firm to deliver scaled execution output without proportional overhead growth.

Name

iO Life Science

Legal name

iO Life Science

Website

https://iolifescience.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

iO Life Science is a Redwood City-based virtual MedTech incubator (founded 2015, 1-10 employees) that partners with MedTech founders and pharma/biotech executives, offering combined funding, regulatory, and engineering services to 20+ startups and enterprise clients including Novartis, AbbVie, and AstraZeneca.

Ownership category

akta.pro rank

Product category

Medical Device Development Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), MLOps/LLMOps & Model Lifecycle Management Services (BPAEAHAH)

Keywords

• Medical device development
• Medtech incubation services
• Drug delivery engineering
• Connected health devices
• Regulatory compliance consulting

Headquarters

HQ city

Redwood City

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Milestone-based professional services (SOWs): Core revenue stream derived from milestone-based Statements of Work (SOWs) covering requirements → prototype → V&V. Hybrid structure preserves flexibility for larger programs while protecting timelines; some well-bounded scopes (e.g., formative HF studies, electromechanical alpha builds) are fixed-fee. Transparent budgets with predictable cost structures (per How We Work page: 100% milestones delivered on time).
2. Equity participation / milestone economics: iO contributes know-how and may receive equity or milestone economics depending on scope (defined in the MSA/SOW). Used to align incentives with founders as part of the shared-risk partnership model.
3. Investment / capital via iO Life Ventures: Through iO Life Ventures, iO supports select programs with direct capital and resources, helping teams progress from ideation to commercialization and co-investing or syndicating alongside engineering services.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

iO Life Science is a virtual MedTech incubator that combines funding (via iO Life Ventures), engineering expertise, and execution power to de-risk and accelerate medical device product development from idea through clinical and manufacturing readiness. The firm delivers shared-risk incubation services across five product categories: drug delivery, diagnostic devices, connected health, surgical systems, and implantables, supported by six integrated capability modules spanning feasibility assessment, human-centered design, rapid prototyping, advanced engineering and simulation, IP strategy, and compliance/reimbursement planning. Engagements are structured as milestone-based Statements of Work, often paired with equity participation or success economics, with iO acting as a fractional COO-style program lead for founders and pharma/biotech executives.

Product overview

iO Life Science operates as a single unified Virtual MedTech Incubator service rather than a multi-module software platform. Its core offering is a shared-risk partnership that combines funding (via iO Life Ventures), engineering expertise, and execution capacity to take medical device programs from concept through clinical and manufacturing readiness. The service is delivered through six interlinked capability modules — Strategic Technology Feasibility Assessment, Human-Centric Design for Better Healthcare, Rapid Prototyping & Iterative Testing, Advanced Engineering & Simulation, IP Protection & Strategy, and Compliance & Reimbursement Strategy — that together support projects across five focus areas: drug delivery (e.g., 3D-Printed Prostate Brachytherapy Delivery System, Digitally Connected Autoinjector (1–1000 cP), High-Viscosity Ocular Drug Delivery), diagnostic devices (e.g., Early Neuro-Monitoring Device, Multi-Sensor Handheld Vital-Signs Monitor), connected health (e.g., Dialysis Wearable Remote-Monitoring), surgical systems (e.g., Renal Access/Support Device), and implantables (e.g., Implantable Oncology Sensor Platform). iO Life Ventures acts as the affiliated investment arm that co-invests or syndicates funding for select programs alongside the incubation services.

Differentiator

Problem solved

Functional benefit

Brands

• iO Life Ventures: Affiliated investment vehicle that supports select MedTech programs with capital and resources, helping teams progress from ideation to commercialization; may co-invest or syndicate.

Products and services

• Virtual MedTech Incubator Service A shared-risk MedTech incubation service that pairs funding, multidisciplinary engineering expertise, and execution capacity to take medical device programs from idea through clinical and manufacturing readiness, across drug delivery, diagnostic devices, connected health, surgical systems, and implantables. Targeted at MedTech founders and pharma/biotech executives who need fractional-COO-style program leadership alongside engineering and regulatory support.
• iO Life Ventures The affiliated investment vehicle through which iO Life Science supports select MedTech programs with capital and resources, helping teams progress from ideation to commercialization. iO Life Ventures may co-invest or help syndicate funding rounds alongside iO's engineering and execution services.

Quantifiable outcome

• 72% faster path from concept to clinical-ready prototype
• +9 more outcomes

Named customers21 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

22 partnerships are on record, tiered flagship, core and minor.

• NovartisflagshipStrategic or Co-development PartnerLeading pharma shown as a client and 'Trusted by Global Leaders' partner on iO's About page. Engaged iO for MedTech innovation, leveraging iO's connected-device, drug-delivery, and combination-product capabilities.
• AbbVieflagshipStrategic or Co-development PartnerLeading pharma shown as a client and 'Trusted by Global Leaders' partner on iO's About page. Engaged iO for MedTech innovation projects.
• AstraZenecaflagshipStrategic or Co-development PartnerLeading pharma shown as a client and 'Trusted by Global Leaders' partner on iO's About page. Engaged iO for MedTech innovation projects.
• Aidar HealthcoreStrategic or Co-development PartnerMobile multisensor monitor startup; CEO Sathya Elumalai provided a testimonial describing iO's role in creating and fine-tuning a working prototype to reach the next stage of investment.
• Alessa TherapeuticscoreStrategic or Co-development PartnerImplantable drug delivery startup; CEO John Maroney provided a testimonial noting iO delivered a successful, compliant device ready for clinical trials with flexible, creative collaboration.
• AliocoreStrategic or Co-development PartnerWearable Medtech startup; CEO David Kuraguntla provided a testimonial praising iO's process for gathering user and stakeholder data and incorporating it into product design.
• ReThink MedicalcoreStrategic or Co-development PartnerWearable Monitor startup; COO Amir Tehrani provided a testimonial praising iO's process for gathering focus-group feedback and observing clinicians interacting with the device.
• Respira TherapeuticscoreStrategic or Co-development PartnerDry-Powder Inhaler startup; CEO Bob Curtis provided a testimonial noting iO produced an amazing product rendering and is a small team capable of handling design from inception to completion.
• OtomagneticscoreStrategic or Co-development PartnerMagnetic Drug Delivery startup; CEO Abhita Vohra provided a testimonial praising iO's high level of experience and unique view during design development.
• KallisiominorStrategic or Co-development PartnerImplantables partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• CereVu MedicalminorStrategic or Co-development PartnerConnected Health / Diagnostics partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• MadorraminorStrategic or Co-development PartnerMedtech partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• Medicines 360minorStrategic or Co-development PartnerPharmaceutical/women's health partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• NephroditeminorStrategic or Co-development PartnerRenal/dialysis partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• NeuravaminorStrategic or Co-development PartnerNeuro-monitoring partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• Starling MedicalminorStrategic or Co-development PartnerConnected Health partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• Surgical AutomationsminorStrategic or Co-development PartnerSurgical automation partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• KodiakminorStrategic or Co-development PartnerMedtech partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• SanaminorStrategic or Co-development PartnerMedtech partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• DoncodiscminorStrategic or Co-development PartnerMedtech partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• AesculatechminorStrategic or Co-development PartnerMedtech partner featured in iO's 'Trusted by Global Leaders' showcase on the About page.
• NanocreativesminorImplementation/ SI/ Consulting PartnerWeb agency credited in site footer ('Made by Nanocreatives') as the designer/builder of iolifescience.com.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ximedica: US-based MedTech design and development services firm covering drug delivery, diagnostics, surgical, and connected devices with integrated human factors and regulatory capabilities — direct overlap with iO's drug delivery and connected health focus.
• Global Center for Medical Innovation (GCMI): Atlanta-based MedTech accelerator and product development resource offering design, prototyping, regulatory, and commercialization services to early-stage medical device companies — a true MedTech incubator peer.
• StarFish Medical: Canada-headquartered MedTech product development firm offering full-spectrum design, engineering, regulatory, and manufacturing services to startups and OEMs. Closest comparable to iO by service mix and target customer (early-stage MedTech and combination-product companies).
• Meddux Development Corporation: Boulder, CO MedTech design and development firm focused on combination products, drug delivery, and surgical devices from concept through transfer to manufacturing — closely mirrors iO's drug delivery and surgical systems projects.
• Donatelle: Minnesota MedTech contract developer and manufacturer serving startups through Class III device programs, including design controls, regulatory support, and production — directly comparable to iO's full lifecycle incubation model.
• Sunrise Labs: Bedford, MA MedTech engineering services firm specializing in Class II/III device development, embedded software, and verification/validation. Highly comparable to iO's regulatory-rigorous, software-heavy connected device work.

Emerging players

• Kernel: Emerging neurotechnology company building wearable brain-measurement devices — overlaps with iO's neuro-monitoring case study on the technology and human factors dimensions, though Kernel is a product company rather than a services firm.

Broad incumbents

• Cambridge Consultants: Large, established product development and technology consultancy with a significant MedTech practice spanning drug delivery, connected health, and surgical systems. Broader portfolio but overlapping target market and capabilities.
• Battelle: Major R&D nonprofit operating across health, life sciences, and national security with MedTech device development, clinical research, and regulatory services — comparable capability scope but at much larger scale and broader mandate.
• Integer Holdings: Large medical device outsource manufacturer and design services provider across drug delivery, cardiac, neuromodulation, and portable medical markets. Adjacent but larger-scale peer in the same end markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/io-life-science
• Xx.com/iO_lifescience

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iO Life Science